We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock

Delisted

ISEE was delisted on the 10th of July, 2023.

101 hedge funds and large institutions have $426M invested in IVERIC bio, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 47 increasing their positions, 25 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

147% more call options, than puts

Call options by funds: $5.44M | Put options by funds: $2.2M

88% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 25

9% more capital invested

Capital invested by funds: $391M → $426M (+$34.8M)

15% less funds holding

Funds holding: 119101 (-18)

27% less funds holding in top 10

Funds holding in top 10: 118 (-3)

62% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 29

Holders
101
Holders Change
-18
Holders Change %
-15.13%
% of All Funds
2.04%
Holding in Top 10
8
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-27.27%
% of All Funds
0.16%
New
11
Increased
47
Reduced
25
Closed
29
Calls
$5.44M
Puts
$2.2M
Net Calls
+$3.24M
Net Calls Change
+$3.07M
Name Holding Trade Value Shares
Change
Change in
Stake
Acadian Asset Management
26
Acadian Asset Management
Massachusetts
$2.89M -$2.08M -436,567 -46%
HP
27
Harbourvest Partners
Massachusetts
$2.5M +$640K +134,270 +44%
N
28
Nuveen
North Carolina
$2.15M +$796K +167,011 +78%
Goldman Sachs
29
Goldman Sachs
New York
$1.96M -$711K -149,111 -30%
DCM
30
DAFNA Capital Management
California
$1.82M -$167K -35,000 -10%
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
$1.61M +$116K +24,400 +9%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$1.43M +$514K +107,694 +74%
Renaissance Technologies
33
Renaissance Technologies
New York
$1.29M -$4.26M -893,200 -80%
AG
34
Algert Global
California
$1.2M +$792K +166,007 +359%
First Trust Advisors
35
First Trust Advisors
Illinois
$1.19M +$1M +210,484 New
Charles Schwab
36
Charles Schwab
California
$1.14M +$451K +94,625 +89%
CC
37
Caxton Corporation
New Jersey
$1.09M +$324K +67,967 +54%
California Public Employees Retirement System
38
California Public Employees Retirement System
California
$1.02M +$391K +81,906 +82%
ASP
39
Adams Street Partners
Illinois
$870K -$736K -154,268 -50%
MIOT
40
Massachusetts Institute of Technology
Massachusetts
$870K -$734K -153,870 -50%
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
$744K +$328K +68,783 +109%
AQR Capital Management
42
AQR Capital Management
Connecticut
$737K +$623K +130,732 New
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$686K +$255K +53,564 +79%
Two Sigma Advisers
44
Two Sigma Advisers
New York
$676K -$62.9K -13,200 -10%
TD Asset Management
45
TD Asset Management
Ontario, Canada
$672K -$30.1K -6,313 -5%
Wells Fargo
46
Wells Fargo
California
$662K +$445K +93,223 +390%
AA
47
ALPS Advisors
Colorado
$644K +$217K +45,588 +67%
Jacobs Levy Equity Management
48
Jacobs Levy Equity Management
New Jersey
$587K -$157K -32,956 -24%
HTC
49
Hershey Trust Company
Pennsylvania
$580K +$163K +34,282 +50%
HS
50
HighVista Strategies
Massachusetts
$541K +$458K +95,975 New

ISEE Hedge Fund Activity: Q3 2020 in Review

101 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q3 2020, worth a combined $426M — up 8.9% from $391M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of ISEE and 11 opened new positions — a net loss of 18 holders — while 25 trimmed existing stakes and 47 added.

The largest buyer was BlackRock, adding an estimated $9.88M. The largest seller was Versant Venture Management, exiting entirely with an estimated $8.8M sold.

  • 101 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q3 2020, down from 119 in Q2 2020.
  • Funds reported $426M of IVERIC bio, Inc. Common Stock stock for Q3 2020, up 8.9% quarter-over-quarter.
  • 11 funds opened new IVERIC bio, Inc. Common Stock positions in Q3 2020 and 29 closed out, a net change of -18 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q3 2020 was BlackRock, an estimated $9.88M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q3 2020 was Versant Venture Management, an estimated $8.8M sold.

Based on aggregated 13F filings for Q3 2020.